Literature DB >> 8420670

Older women as the focus for research and treatment of ovarian cancer. An overview for the National Institute on Aging, National Cancer Institute, and American Cancer Society Multidisciplinary Working Conference.

R Yancik1, T D Moore, G Martin, G I Obrams, E Reed.   

Abstract

Ovarian cancer disproportionately affects women 65 years of age and older who are likely to have concomitant changes in physical ability, physiological functioning, and other chronic conditions associated with advancing age. The National Institute on Aging, National Cancer Institute, and the American Cancer Society cosponsored a multidisciplinary working conference, "Perspectives on Ovarian Cancer in Older-Aged Women: Current Knowledge and Recommendations for Research," at the National Institutes of Health on November 20-21, 1991 to confront the age-related aspects of ovarian cancer in epidemiology, etiology, clinical investigations, and patient management. Conference participants devoted attention to such special topics as drug resistance, dose intensity, patterns of care, and screening potential for ovarian cancer. After exploring these areas with existing data, the task was then to generate recommendations for research and practice. The scope of the conference and an introduction to the proceedings are presented in this paper.

Entities:  

Mesh:

Year:  1993        PMID: 8420670     DOI: 10.1002/cncr.2820710204

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  1 in total

1.  Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group.

Authors:  Yolaine Joueidi; Ludivine Dion; Sofiane Bendifallah; Camille Mimoun; Alexandre Bricou; Krystel Nyangoh Timoh; Pierre Collinet; Cyril Touboul; Lobna Ouldamer; Henri Azaïs; Yohann Dabi; Cherif Akladios; Geoffroy Canlorbe; Pierre-Adrien Bolze; Hélène Costaz; Mathieu Mezzadri; Tristan Gauthier; Frederic Kridelka; Pauline Chauvet; Nicolas Bourdel; Martin Koskas; Xavier Carcopino; Emilie Raimond; Olivier Graesslin; Lise Lecointre; Marcos Ballester; Cyrille Huchon; Jean Levêque; Vincent Lavoué
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.